Sinuhe Hahn

Title: Sinuhe Hahn: Innovator in Non-Invasive Genetic Testing

Introduction

Sinuhe Hahn is a notable inventor based in Liestal, Switzerland. He has made significant contributions to the field of genetic testing, particularly in non-invasive methods for detecting fetal genetic traits. With a total of 3 patents to his name, his work has the potential to revolutionize prenatal care.

Latest Patents

One of Sinuhe Hahn's latest patents focuses on the non-invasive detection of fetal genetic traits. This innovative method utilizes blood plasma from pregnant women, which contains both fetal and maternal circulatory extracellular DNA. Most of the fetal DNA consists of fragments that are less than or equal to 500 base pairs, while maternal DNA is generally larger. By employing techniques such as chromatography, density gradient centrifugation, or nanotechnology, Hahn's method allows for the separation of fetal DNA from maternal DNA. This separation enables the detection of various fetal genetic traits, including the fetal RhD gene, Y chromosome-specific sequences, chromosomal aberrations, and hereditary Mendelian genetic disorders. The techniques used for detection include PCR, ligand chain reaction, probe hybridization, and nucleic acid arrays.

Career Highlights

Sinuhe Hahn has established himself as a key figure in the field of genetic research. His work at Sequenom, Inc. has been instrumental in advancing non-invasive prenatal testing methods. His innovative approaches have garnered attention and recognition within the scientific community.

Collaborations

Hahn collaborates with notable professionals in his field, including Wolfgang Holzgreve. Their combined expertise contributes to the advancement of genetic testing technologies.

Conclusion

Sinuhe Hahn's contributions to non-invasive genetic testing represent a significant advancement in prenatal care. His innovative methods have the potential to improve the accuracy and safety of genetic testing for expectant mothers.